riluzole has been researched along with Bulbar Palsy in 6 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Riluzole is to date the only treatment that prolongs amyotrophic lateral sclerosis (ALS) survival." | 7.74 | Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy. ( Beghi, E; Fraddosio, A; Guerra, V; Lamberti, P; Lepore, V; Logroscino, G; Palagano, G; Samarelli, V; Serlenga, L; Simone, IL; Zoccolella, S, 2007) |
| "To investigate the impact of epidemiological and clinical factors on the benefit of riluzole in patients with amyotrophic lateral sclerosis (ALS)." | 3.85 | Epidemiological and clinical factors impact on the benefit of riluzole in the survival rates of patients with ALS. ( Caromano, FA; Castro, I; Fávero, FM; Oliveira, ASB; Voos, MC, 2017) |
| "Riluzole is to date the only treatment that prolongs amyotrophic lateral sclerosis (ALS) survival." | 3.74 | Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy. ( Beghi, E; Fraddosio, A; Guerra, V; Lamberti, P; Lepore, V; Logroscino, G; Palagano, G; Samarelli, V; Serlenga, L; Simone, IL; Zoccolella, S, 2007) |
| "Amyotrophic lateral sclerosis (ALS) is the most common adult-onset motor neuron disease." | 2.43 | Diagnostic investigation and multidisciplinary management in motor neuron disease. ( Fonseca, J; Mendes Ribeiro, J; Reis, C; Rocha, JA; Simões, F, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fávero, FM | 1 |
| Voos, MC | 1 |
| Castro, I | 1 |
| Caromano, FA | 1 |
| Oliveira, ASB | 1 |
| Wei, Q | 1 |
| Chen, X | 1 |
| Zheng, Z | 1 |
| Huang, R | 1 |
| Guo, X | 1 |
| Cao, B | 1 |
| Zhao, B | 1 |
| Shang, H | 1 |
| Shamshiri, H | 1 |
| Fatehi, F | 1 |
| Davoudi, F | 1 |
| Mir, E | 1 |
| Pourmirza, B | 1 |
| Abolfazli, R | 1 |
| Etemadifar, M | 1 |
| Harirchian, MH | 1 |
| Gharagozli, K | 1 |
| Ayromlou, H | 1 |
| Basiri, K | 1 |
| Zamani, B | 1 |
| Rohani, M | 1 |
| Sedighi, B | 1 |
| Roudbari, A | 1 |
| Delavar Kasmaei, H | 1 |
| Nikkhah, K | 1 |
| Ranjbar Naeini, A | 1 |
| Nafissi, S | 1 |
| Brooks, BR | 1 |
| Sanjak, M | 1 |
| Rocha, JA | 1 |
| Reis, C | 1 |
| Simões, F | 1 |
| Fonseca, J | 1 |
| Mendes Ribeiro, J | 1 |
| Zoccolella, S | 1 |
| Beghi, E | 1 |
| Palagano, G | 1 |
| Fraddosio, A | 1 |
| Guerra, V | 1 |
| Samarelli, V | 1 |
| Lepore, V | 1 |
| Simone, IL | 1 |
| Lamberti, P | 1 |
| Serlenga, L | 1 |
| Logroscino, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treatment Effect of Edaravone in Patients With Amyotrophic Lateral Sclerosis (ALS) in a Representative Iranian Population[NCT03272802] | Phase 2/Phase 3 | 20 participants (Anticipated) | Interventional | 2017-03-16 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for riluzole and Bulbar Palsy
| Article | Year |
|---|---|
Diagnostic investigation and multidisciplinary management in motor neuron disease.
Topics: Amyotrophic Lateral Sclerosis; Bulbar Palsy, Progressive; Diagnosis, Differential; Diagnostic Imagin | 2005 |
1 trial available for riluzole and Bulbar Palsy
| Article | Year |
|---|---|
Disease-modifying drug therapies.
Topics: Adult; Age Factors; Age of Onset; Amyotrophic Lateral Sclerosis; Antirheumatic Agents; Bulbar Palsy, | 2004 |
4 other studies available for riluzole and Bulbar Palsy
| Article | Year |
|---|---|
Epidemiological and clinical factors impact on the benefit of riluzole in the survival rates of patients with ALS.
Topics: Amyotrophic Lateral Sclerosis; Brazil; Bulbar Palsy, Progressive; Electromyography; Female; Humans; | 2017 |
Clinical features of amyotrophic lateral sclerosis in south-west China.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Bulbar Palsy, Progressi | 2015 |
Amyotrophic lateral sclerosis progression: Iran-ALS clinical registry, a multicentre study.
Topics: Adult; Amyotrophic Lateral Sclerosis; Bulbar Palsy, Progressive; Disease Progression; Extremities; F | 2015 |
Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.
Topics: Adult; Age Distribution; Age Factors; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Bulbar | 2007 |